RE:EDEN could be significant in expanding the labelSpectral certainly likes their Biblical references.
This study will be very significant I suspect. It may lead to an earlier ending of the trial as well.
As always, and as MM said, the share price is whatever they want it to be and today they decided that a 15% haircut after the Veteran's Administration deal was an appropriate close. What else would a 50 cent, 32 person company do after inking a major dialysis deal within the largest healthcare network in the United States?
Of course it would lose 15%... maybe more.
Meaningless! It is and always has been meaningless.
The company has made infinite leaps forward in the last several weeks and is closer than ever to where the 90% of insider shares want it to be.
If people are jittery they should sell.